scispace - formally typeset
C

Christopher J. Lengner

Researcher at University of Pennsylvania

Publications -  133
Citations -  12605

Christopher J. Lengner is an academic researcher from University of Pennsylvania. The author has contributed to research in topics: Stem cell & Wnt signaling pathway. The author has an hindex of 47, co-authored 107 publications receiving 11054 citations. Previous affiliations of Christopher J. Lengner include Cardiovascular Institute of the South & Massachusetts Institute of Technology.

Papers
More filters
Journal ArticleDOI

Canonical WNT Signaling Promotes Osteogenesis by Directly Stimulating Runx2 Gene Expression

TL;DR: It is proposed that WNT/TCF1 signaling, like bone morphogenetic protein/transforming growth factor-β signaling, activates Runx2 gene expression in mesenchymal cells for the control of osteoblast differentiation and skeletal development.
Journal ArticleDOI

Direct cell reprogramming is a stochastic process amenable to acceleration

TL;DR: Quantitative analyses define distinct cell-division-rate-dependent and -independent modes for accelerating the stochastic course of reprogramming, and suggest that the number of cell divisions is a key parameter driving epigenetic reprograming to pluripotency.
Journal ArticleDOI

Sequential Expression of Pluripotency Markers during Direct Reprogramming of Mouse Somatic Cells

TL;DR: Using inducible constructs derived induced pluripotent stem (iPS) cells from mouse embryonic fibroblasts (MEFs) and found that transgene silencing is a prerequisite for normal cell differentiation, a step toward understanding some of the molecular events governing epigenetic reprogramming.
Journal ArticleDOI

Direct Reprogramming of Terminally Differentiated Mature B Lymphocytes to Pluripotency

TL;DR: This study provides definite proof for the direct nuclear reprogramming of terminally differentiated adult cells to pluripotency through transgenic and inducible expression of transcription factors.
Journal ArticleDOI

Human embryonic stem cells with biological and epigenetic characteristics similar to those of mouse ESCs

TL;DR: The generation of validated “naïve” human ESCs will allow the molecular dissection of a previously undefined pluripotent state in humans and may open up new opportunities for patient-specific, disease-relevant research.